scispace - formally typeset
N

Naohiko Seki

Researcher at Chiba University

Publications -  391
Citations -  20245

Naohiko Seki is an academic researcher from Chiba University. The author has contributed to research in topics: microRNA & Cancer. The author has an hindex of 74, co-authored 381 publications receiving 18648 citations. Previous affiliations of Naohiko Seki include Toho University & National Institute of Radiological Sciences.

Papers
More filters
Journal ArticleDOI

Identification of Tumor-Suppressive miR-30e-3p Targets: Involvement of SERPINE1 in the Molecular Pathogenesis of Head and Neck Squamous Cell Carcinoma

TL;DR: This study addressed target genes controlled by miR-30e-3p that were closely associated with the molecular pathogenesis of head and neck squamous cell carcinoma (HNSCC) and found that SERPINE1 was found to be an independent prognostic factor for patient survival.
Journal ArticleDOI

1270 micrornas detection in urine as diagnostic markers and predictors of recurrence of non-muscle invasive bladder cancer

TL;DR: The data suggest that detection ofmiR-96 and miR-183 may serve as potential biomarkers for BC diagnosis as well as prediction for tumor recurrence of non-muscle invasive BC.
Patent

Heart20049410 polypeptides and methods of making the same

TL;DR: In this paper, the full-length nucleotide sequences of the cDNA and amino acid sequences encoded by the nucleotide sequence have been determined, and they provide information useful for analyzing the functions of the polypeptide.
Patent

FULL-LENGTH cDNA AND POLYPEPTIDES

Abstract: cDNA derived from human have been isolated. The full-length nucleotide sequences of the cDNA and amino acid sequences encoded by the nucleotide sequences have been determined. Because the cDNA of the present invention are full-length and contain the translation start site, they provide information useful for analyzing the functions of the polypeptide.
Proceedings ArticleDOI

Abstract 132:miR-133aas a tumor suppressive microRNA targeting multiple oncogenes in head neck squamous cell carcinoma

TL;DR: Tumor suppressive miR-133a and its target oncogenes may provide new insights into the mechanisms in cancer and have therapeutic implications and may be exploited for future HNSCC treatments.